知镜 Cognispect · 医学文献与研究工作台

Palladium-103 brachytherapy with continuous periodic intravitreal Anti-VEGF bevacizumab for ciliary body medulloepithelioma

Wingate SL, Finger PT.
Am J Ophthalmol Case Rep · 2026-10-24 · PMID 42990772

文献摘要

Purpose To report a case of medulloepithelioma treated with palladium-103 ( 103 Pd) plaque brachytherapy, followed by adjunctive continuous periodic intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy, highlighting a novel combined strategy for tumor control and management of its neovascular complications. Observations A 9-year-old male presented with a ciliary body mass causing anterior displacement of the iris and iris neovascularization in the right eye. Initial tumor dimensions were 8 × 8 mm in basal diameters and 3.9 mm in thickness. Aspiration cutter-assisted biopsy was used to confirm the diagnosis of medulloepithelioma. Treatment involved temporary placement of a 14-mm 103 Pd plaque, which irradiated the tumor's apex to 101.4 Gy (Gy) over 7 days. Despite tumor control, progressive iris neovascularization with secondary angle-closure glaucoma was managed by continuous periodic intravitreal anti-VEGF pharmacotherapy and two peripheral iridotomies. At 18 months post-plaque brachytherapy, a posterior subcapsular cataract developed that required extraction with intraocular lens placement. At 5 years post-plaque brachytherapy, a macular epiretinal membrane developed that was pealed during pars plana vitrectomy surgery. At 6 years 2 months follow-up post-plaque brachytherapy the tumor's thickness had decreased from 3.9 to 2.1 mm (46.2%) and the visual acuity had declined from 20/20 to 20/63. No metastases were detected. Conclusions and importance 103 Pd plaque brachytherapy was used to control a ciliary body medulloepithelioma. However, iridotomies and continuous periodic anti-VEGF therapy were needed to suppress tumor-related secondary neovascular glaucoma. This approach achieved durable local tumor control while preserving the globe and functional vision. Targeted radiation and pharmacologic neovascular suppression offered a novel globe and vision-sparing treatment for medulloepithelioma.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。